5-Bromopyrido[3,4-b]pyrazine, 97%, 250mg

Methyl 4-aminopyrimidine-5-carboxylate, 95.0%, 250mg

2-Chloro-7-fluoroquinoxaline, 98+%, 250mg

(E)-5-(3-METHYLTRIAZ-1-EN-1-YL)-1H-IMIDAZOLE-4-CARBOXAMIDE, 95.0%, 250mg

n-Decyltrimethoxysilane, = 97% (GC), 100g

Disodium tetraborate decahydrate, min. 99%, Ph.Eur., BP, NF, 1 kg, plastic packaging.

Thieno[3,2-b]thiophene-2,5-dicarboxaldehyde>93.0%(GC)200mg

Ethyl 2-(5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)acetate hydrochloride, 95+%, 100mg

3-Nitro-2-pyrrolidin-1-ylpyridine, 97.0%, 5g

3-(4-(BROMOMETHYL)PHENYL)-3-(TRIFLUOROMETHYL)-3H-DIAZIRINE, 95%, 1g

1-Methyl-4-nitro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE, 95%, 250mg

4,6-difluoro-N-(2-morpholin-4-ylethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg